AI assistant
Sending…
IONIS PHARMACEUTICALS INC — Director's Dealing 2019
Jun 12, 2019
30591_dirs_2019-06-12_f120c05f-444d-4b94-9f2c-d31349b8c66a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: IONIS PHARMACEUTICALS INC (IONS)
CIK: 0000874015
Period of Report: 2019-06-10
Reporting Person: HERMAN JOAN E (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| No Securities Owned | 0 | Direct |
More from IONIS PHARMACEUTICALS INC
Regulatory Filings
2026
May 28
Major Shareholding Notification
2026
Apr 30
Interim / Quarterly Report
2026
Apr 29
Earnings Release
2026
Apr 29
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Apr 21
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 24